NKTR Financials
Nektar Therapeutics - Financial statements & key metrics
Stock Price
$72.00
Market Cap
$307.19M
P/E Ratio
-124.1
EPS
$-9.83
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$98.43M
Gross Profit
-
Operating Income
-
Net Income
$-118.96M
EPS (Diluted)
$-0.58
Balance Sheet Highlights
Total Assets
$303.85M
Total Liabilities
$243.11M
Shareholders Equity
-
Cash & Equivalents
$44.25M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-175.71M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-267.4%
Net Margin
-192.9%
ROE
-180.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is NKTR revenue?
NKTR's most recent quarterly revenue was $98.43M. Annual revenue can be calculated by summing the four most recent quarters.
Is NKTR profitable?
NKTR reported a loss of $118.96M in the most recent quarter. The net profit margin is -192.9%.
What is NKTR market cap?
NKTR has a market capitalization of $307.19M, making it a small-cap stock.
Does NKTR have debt?
View NKTR's balance sheet for debt information.
What is NKTR cash flow?
Cash flow data is available in the full financial statements.